San Antonio Breast Cancer Symposium 2026
A page on meetings in our medical research coverage, part of our health reporting, alongside the 18 reports filed on it so far.
Natera partners with Angiex on cancer trial
Natera has partnered with Angiex to evaluate its Signatera blood test in a phase 1 trial of the cancer drug AGX101.
mRNA cancer vaccine trial succeeds
A personalized mRNA vaccine for melanoma from Moderna and Merck has shown clinical success, offering a potential boost for the mRNA field after...
T Cell Therapy Treats Atopic Dermatitis
A Lancet comment published August 21, 2026, discusses rezpegaldesleukin, a novel therapy designed to expand regulatory T cells for treating
BioNTech-Genentech cancer vaccine trial
BioNTech and Genentech ended a trial of their mRNA cancer vaccine after more deaths occurred in the vaccinated group versus the observation group.
FDA clears three updated COVID-19 vaccines
The FDA approved updated COVID-19 vaccines from Pfizer, Moderna, and Novavax. Moderna also raised $2.6 billion for its cancer drug business.
Lancet warns of new biosecurity risks
A Lancet editorial published on August 29, 2026, argues that political focus on COVID-19 origins is hindering preparedness for emerging biosecurity...
AstraZeneca halts cancer drug trial in setback
AstraZeneca halts cancer drug trial in setback. A target trial emulation of adults with serious mental illness (SMI) found GLP-1 receptor agonists...
Revolution's pancreatic cancer drug Rasonque cleared by FDA
Revolution Medicines' pancreatic cancer therapy Rasonque cleared FDA approval via priority review voucher, marking a major advance for second-line...
Revolution Medicines' Rasonque Approved for Pancreatic Cancer
The FDA has approved Rasonque, a new pancreatic cancer drug by Revolution Medicines, marking the first treatment to target a genetic cause of the...
Daraxonrasib Approved for Metastatic Pancreatic Cancer
The FDA has granted approval to the RAS inhibitor daraxonrasib for adults with metastatic pancreatic ductal adenocarcinoma who have progressed on...
Akeso’s Biliary Tract Win Shows ivonescimab Beyond Lung Cancer
Akeso’s CEO highlights a phase-3 success in biliary tract cancer while defending the drug’s data amid NSCLC concerns.
Moderna-Merck Cancer Vaccine
Moderna and Merck's individualized cancer vaccine shows promise in Phase 3 trial for melanoma
Focal Therapy
Focal therapy for prostate cancer has divided physicians, with some considering it a viable alternative to traditional treatments and others viewing...
UK feasibility trial finds psilocybin therapy safe for resistant depression
A 2026 feasibility study delivering psilocybin-assisted therapy within the NHS reported high adherence and no safety concerns, raising questions...
FDA Commissioner Nominee Announced, mRNA Cancer Vaccine Shows Promise
The White House is expected to nominate Heidi Overton as the next commissioner of the U.S. Food and Drug Administration. Meanwhile, a late-stage...
American Cancer Society Cancels Alcohol Industry Fundraiser
The American Cancer Society has canceled its upcoming Wine and Spirits Industry’s Gala, a spokesperson confirmed.
AstraZeneca Lung Cancer Trial Setback, Falling U.S. Drug Prices
AstraZeneca discontinues a late-stage trial for its experimental drug volrustomig, while prescription drug prices in the U.S. experience a...
FDA Approves Bristol Myers Squibb’s Zenbexus for Advanced Multiple Myeloma, Marking Debut of New Drug Class
The U.S. FDA has approved Zenbexus, Bristol Myers Squibb’s oral treatment for advanced multiple myeloma, introducing a new class of blood cancer...